middle.news
Island Pharmaceuticals Secures Key Marburg Data to Advance Galidesivir FDA Submission
9:01am on Monday 31st of August, 2026 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Secures Key Marburg Data to Advance Galidesivir FDA Submission
9:01am on Monday 31st of August, 2026 AEST
Key Points
Letter of Authorisation grants access to detailed Marburg natural history data
Addresses FDA feedback requiring full study report for regulatory review
Avoids costly replication of specialized BSL-4 primate studies
Supports upcoming USAMRIID and Texas Biomed efficacy trials
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE